Importance of collection in gene set enrichment analysis of drug response in cancer cell lines

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Bateman, Alain R ^a   El Hachem, Nehme ^a   Beck, Andrew H ^b   Aerts, Hugo J W L ^c,d,e   Haibe Kains, Benjamin ^a,f  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ALGORITHM; BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PROCEDURES; TUMOR CELL LINE;

ALGORITHMS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; NEOPLASMS; PHARMACEUTICAL PREPARATIONS;

EID: 84920669101     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04092     Document Type: Article

References (36)

1. Lockhart, D. J. et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotech 14, 1675-1680 (1996).
2. Shi, L. et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 24, 1151-1161 (2006).
3. Haibe-Kains, B. et al. A Three-Gene Model to Robustly Identify Breast Cancer Molecular Subtypes. JNCI J. Natl. Cancer Inst. 104, 311-325 (2012).
4. Hung, J.-H., Yang, T.-H., Hu, Z., Weng, Z. & DeLisi, C. Gene set enrichment analysis: performance evaluation and usage guidelines. Brief. Bioinform. 13, 281-291 (2011).
5. Maciejewski, H. Gene set analysis methods: statistical models and methodological differences. Brief. Bioinform. DOI:10.1093/bib/bbt002 (2013).
6. Weinstein, J. N. Drug discovery: Cell lines battle cancer. Nature 483, 544-545 (2012).
7. Shoemaker, R. H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 6, 813-823 (2006).
8. Garnett, M. J. et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570-575 (2012).
9. Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603-307 (2012).
10. Sherman-Baust, C. A., Becker, K. G., Wood Iii, W. H., Zhang, Y. & Morin, P. J. Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin. J Ovarian Res 4, 21 (2011).
11. Rusnak, D. W. et al. Assessment of epidermal growth factor receptor (EGFR, ErbB1) and HER2 (ErbB2) protein expression levels and response to lapatinib (TykerbH, GW572016) in an expanded panel of human normal and tumour cell lines. Cell Prolif. 40, 580-594 (2007).
12. Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27-30 (2000).
13. Croft, D. et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 39, D691-D697 (2010).
14. Subramanian, A. et al.Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102, 15545-15550 (2005).
15. Sheskin, David J. in Handb. Parametr. Nonparametric Stat. Proced. 261-276 (Chapman & Hall, 2011).
16. Subramanian, A., Kuehn, H., Gould, J., Tamayo, P. & Mesirov, J. P. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 23, 3251-3253 (2007).
17. Liberzon, A. et al.Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739-1740 (2011).
18. Hirsch, J. E. An index to quantify an individual's scientific research output. Proc. Natl. Acad. Sci. U. S. A. 102, 16569-16572 (2005).
19. Levandowsky, M. &Winter, D. Distance between Sets. Nature 234, 34-35 (1971).
20. Greshock, J. et al.Molecular Target Class Is Predictive of In vitro Response Profile. Cancer Res. 70, 3677-3686 (2010).
21. R Core Team. R: A Language and Environment for Statistical Computing. (R Foundation for Statistical Computing, 2013). at,http://www.R-project.org..
22. Ashburner, M. et al.Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25-29 (2000).
23. Franceschini, A. et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808-D815 (2012).
24. Jaeger, J. et al. Gene Expression Signatures for Tumor Progression, Tumor Subtype, and Tumor Thickness in Laser-Microdissected Melanoma Tissues. Clin. Cancer Res. 13, 806-815 (2007).
25. Morin, P. J. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res. 65, 9603-9606 (2005).
26. Lu, Z. et al. Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway. Exp. Cell Res. 317, 1935-1946 (2011).
27. Hoggard, J. et al. Claudin-7 increases chemosensitivity to cisplatin through the upregulation of caspase pathway in human NCI-H522 lung cancer cells. Cancer Sci. 104, 611-618 (2013).
28. Coldren, C. D. Baseline Gene Expression Predicts Sensitivity to Gefitinib in Non- Small Cell Lung Cancer Cell Lines. Mol. Cancer Res. 4, 521-528 (2006).
29. Peroval, M. Y., Boyd, A. C., Young, J. R. & Smith, A. L. A Critical Role for MAPK Signalling Pathways in the Transcriptional Regulation of Toll Like Receptors. PLoS ONE 8, e51243 (2013).
30. Tripathi, S., Glazko, G. V. & Emmert-Streib, F. Ensuring the statistical soundness of competitive gene set approaches: gene filtering and genome-scale coverage are essential. Nucleic Acids Res. 41, e82-e82 (2013).
31. Newman, J. C. & Weiner, A. M. L2L: a simple tool for discovering the hidden significance in microarray expression data. Genome Biol. 6, R81 (2005).
32. Xie, X. et al. Systematic discovery of regulatory motifs in human promoters and 39 UTRs by comparison of several mammals. Nature 434, 338-345 (2005).
33. Wingender, E. et al. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res. 28, 316-319 (2000).
34. Segal, E., Friedman,N., Koller, D.& Regev, A. Amodule map showing conditional activity of expression modules in cancer. Nat. Genet. 36, 1090-1098 (2004).
35. Brentani, H. et al. The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc. Natl. Acad. Sci. 100, 13418-13423 (2003).
36. Haibe-Kains, B., El-Hachem, N., Birkbak, N. J., Jin, A. C, Beck, A. H., Aerts, H. J. W. L. & Quackenbush, J. Inconsistency in large pharmacogenomic studies. Nature, 504(7480), 389-393. doi:10.1038/nature12831 (2013).